Key facts
- This page summarizes David Scott Tomsche's Form 4 filing for IMMUCELL CORP /DE/ (ICCC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 30 Aug 2024, 12:25.
David Scott Tomsche - 28 Aug 2024 Form 4 Insider Report for IMMUCELL CORP /DE/ (ICCC)
- Reporting relationship
- Director
- Issuer ticker
- ICCC
- Reported as of
- 28 Aug 2024
- Net transaction value
- +$7,760
- SEC form
- 4
- Accepted by SEC
- 30 Aug 2024, 12:25:45 UTC
- Prior SEC filing
- 26 Aug 2024
- Next SEC filing
- 24 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael F Brigham Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
David Scott Tomsche filed Form 4 for IMMUCELL CORP /DE/ (ICCC) on 30 Aug 2024.
Change
- Previous filing in this sequence was filed on 26 Aug 2024.
- Current net transaction value: +$7,760.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ICCC
transaction
Common stock $0.10 per value per share
Disposed to Issuer
- Transaction value
- $7,760
- Shares
- +2,186
- Change %
- +1.7%
- Price
- $3.55
- Shares after
- 131,797
- Date
- 28 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
(1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.